Another work explored the effect of EGCG on the aggregation process and toxicity of the expanded ataxin-3 (AT3), the polyglutamine (polyQ)-containing protein responsible for spinocerebellar ataxia type 3 (SCA3) [221]. The gene discussed is ATXN3; the disease is Spinocerebellar ataxia type 3.